U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Fallopian Tube Clear Cell Adenocarcinoma

MedGen UID:
1770402
•Concept ID:
C5418776
•
Neoplastic Process

Definition

The reemergence of fallopian tube clear cell adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Fallopian Tube Clear Cell Adenocarcinoma

Professional guidelines

PubMed

A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KH
Gynecol Oncol 2017 Aug;146(2):399-404. Epub 2017 Jun 10 doi: 10.1016/j.ygyno.2017.05.037. PMID: 28610746Free PMC Article
Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?
Rocconi RP, Sullivan P, Long B, Blaize M, Brown J, Arbuckle J, Bevis K, Estes JM, Reed E, Finan MA
Int J Gynecol Cancer 2012 Jun;22(5):786-91. doi: 10.1097/IGC.0b013e31825104f4. PMID: 22552832
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller.
Chi DS, Barlin JN, Ramirez PT, Levenback CF, Mironov S, Sarasohn DM, Iyer RB, Dao F, Hricak H, Barakat RR
Int J Gynecol Cancer 2010 Apr;20(3):353-7. doi: 10.1111/IGC.0b013e3181d09fd6. PMID: 20375796

Recent clinical studies

Etiology

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
Bao L, Ding Y, Cai Q, Ning Y, Hu W, Xue X, Sun H, Hua K, Zhou X, Yi X
Int J Gynecol Cancer 2016 Mar;26(3):424-30. doi: 10.1097/IGC.0000000000000648. PMID: 26825825
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W
Hum Pathol 2015 Jun;46(6):858-67. Epub 2015 Mar 5 doi: 10.1016/j.humpath.2015.02.012. PMID: 25841306
Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
Khemapech N, Oranratanaphan S, Termrungruanglert W, Lertkhachonsuk R, Vasurattana A
Asian Pac J Cancer Prev 2013;14(3):2131-5. doi: 10.7314/apjcp.2013.14.3.2131. PMID: 23679331
Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma.
Suprasert P, Cheewakriangkrai C, Manopunya M
Asian Pac J Cancer Prev 2012;13(2):517-20. doi: 10.7314/apjcp.2012.13.2.517. PMID: 22524817

Diagnosis

Skin metastases in epithelial ovarian and fallopian tube carcinoma.
Otsuka I, Matsuura T
Medicine (Baltimore) 2017 Aug;96(33):e7798. doi: 10.1097/MD.0000000000007798. PMID: 28816970Free PMC Article
Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
Bao L, Ding Y, Cai Q, Ning Y, Hu W, Xue X, Sun H, Hua K, Zhou X, Yi X
Int J Gynecol Cancer 2016 Mar;26(3):424-30. doi: 10.1097/IGC.0000000000000648. PMID: 26825825
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W
Hum Pathol 2015 Jun;46(6):858-67. Epub 2015 Mar 5 doi: 10.1016/j.humpath.2015.02.012. PMID: 25841306
Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?
Reitsma W, de Bock GH, Oosterwijk JC, ten Hoor KA, Hollema H, Mourits MJ
Int J Gynecol Cancer 2012 May;22(4):579-85. doi: 10.1097/IGC.0b013e31823d1b5c. PMID: 22274543
Primary clear cell adenocarcinoma of the fallopian tube with brain metastasis: a case report.
Ryuko K, Iwanari O, Abu-Musa A, Fujiwaki R, Kitao M
Asia Oceania J Obstet Gynaecol 1994 Jun;20(2):135-40. doi: 10.1111/j.1447-0756.1994.tb00439.x. PMID: 8092957

Therapy

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001).
Konstantinopoulos PA, Brady WE, Farley J, Armstrong A, Uyar DS, Gershenson DM
Gynecol Oncol 2018 Jul;150(1):9-13. Epub 2018 May 5 doi: 10.1016/j.ygyno.2018.04.572. PMID: 29739622Free PMC Article
Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
Bao L, Ding Y, Cai Q, Ning Y, Hu W, Xue X, Sun H, Hua K, Zhou X, Yi X
Int J Gynecol Cancer 2016 Mar;26(3):424-30. doi: 10.1097/IGC.0000000000000648. PMID: 26825825
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
Ahmed N, Abubaker K, Findlay J, Quinn M
J Cell Biochem 2013 Jan;114(1):21-34. doi: 10.1002/jcb.24317. PMID: 22887554
Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma.
Suprasert P, Cheewakriangkrai C, Manopunya M
Asian Pac J Cancer Prev 2012;13(2):517-20. doi: 10.7314/apjcp.2012.13.2.517. PMID: 22524817

Prognosis

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
Skin metastases in epithelial ovarian and fallopian tube carcinoma.
Otsuka I, Matsuura T
Medicine (Baltimore) 2017 Aug;96(33):e7798. doi: 10.1097/MD.0000000000007798. PMID: 28816970Free PMC Article
Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
Bao L, Ding Y, Cai Q, Ning Y, Hu W, Xue X, Sun H, Hua K, Zhou X, Yi X
Int J Gynecol Cancer 2016 Mar;26(3):424-30. doi: 10.1097/IGC.0000000000000648. PMID: 26825825
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W
Hum Pathol 2015 Jun;46(6):858-67. Epub 2015 Mar 5 doi: 10.1016/j.humpath.2015.02.012. PMID: 25841306
Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma.
Suprasert P, Cheewakriangkrai C, Manopunya M
Asian Pac J Cancer Prev 2012;13(2):517-20. doi: 10.7314/apjcp.2012.13.2.517. PMID: 22524817

Clinical prediction guides

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
Primary Fallopian Tube Carcinoma: A Single-Institution Experience of 101 Cases: A Retrospective Study.
Bao L, Ding Y, Cai Q, Ning Y, Hu W, Xue X, Sun H, Hua K, Zhou X, Yi X
Int J Gynecol Cancer 2016 Mar;26(3):424-30. doi: 10.1097/IGC.0000000000000648. PMID: 26825825
Expression of LATS family proteins in ovarian tumors and its significance.
Xu B, Sun D, Wang Z, Weng H, Wu D, Zhang X, Zhou Y, Hu W
Hum Pathol 2015 Jun;46(6):858-67. Epub 2015 Mar 5 doi: 10.1016/j.humpath.2015.02.012. PMID: 25841306
Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies.
Wooten CE, Randall M, Edwards J, Aryal P, Luo W, Feddock J
Gynecol Oncol 2014 May;133(2):268-73. Epub 2014 Feb 17 doi: 10.1016/j.ygyno.2014.02.015. PMID: 24556059
Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovary.
Georgakopoulos P, Mehmood S, Akalin A, Shroyer KR
Int J Gynecol Pathol 2012 Nov;31(6):517-23. doi: 10.1097/PGP.0b013e31824fe269. PMID: 23018214

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...